GlaxoSmithKline, s.r.o. is a Czech Republic-based subsidiary of the British multinational pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in Brentford, London. As of March 2014, it was the world's sixth-largest pharmaceutical Company by revenues. The Company was established in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham plc. GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions, the biggest selling of which were Advair, Avodart, Flovent, Augmentin, Lovaza, and Lamictal.
This report offers a summary of the company's performance in 2003-2013. You will find here all the key numbers from the company's balance sheet, income statement and cash flow on the annual, in the local currency as well as in USD